Abstract
The search for new antiarrhythmic agents has been intense, because the established drugs for the treatment of cardiac arrhythmias are neither uniformly effective nor well-tolerated. Among the recently introduced new antiarrhythmic agents are tocainide (TOC), mexiletine (MEX), flecainide (FLE), and propafenone (PRO). Each of these drugs is a chiral amine used clinically as the racemic mixture. We have examined the high-performance liquid chromatographic chiral resolution of the above four drugs via derivatization with homochiral derivatizing agents (HDAs). The amino functionality of the drugs was reacted with four homochiral isothiocyanates, 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl isothiocyanate (TAGIT), (R)-alpha-methylbenzyl isothiocyanate (RAMBI), (S)-1-(1-naphthyl)ethyl isothiocyanate (SNEIT), and (R)-1-(2-naphthyl)ethyl isothiocyanate (RBEIT). Complete separation of the two peaks (resolution factor R = 1.5) was achieved with all four HDAs for TOC, with TAGIT, RBEIT, and RAMBI for MEX, with TAGIT and SNEIT for PRO, and only with TAGIT for FLE. SNEIT was used to develop analytical procedures for the determination of the enantiomeric composition of TOC in human urine and blood serum. The four HDAs offer several advantages...Continue Reading
References
Oct 1, 1979·Journal of Medicinal Chemistry·E W ByrnesP A Tenthorey
Dec 1, 1976·Circulation·R A WinkleD C Harrison
May 1, 1976·Circulation·M NakazawaJ M Jarmakani
Feb 1, 1988·Journal of Cardiovascular Pharmacology·A J BlockE R Smith
Feb 1, 1988·Journal of Cardiovascular Pharmacology·A C UprichardD W Harron
Jan 1, 1988·Journal of Cardiovascular Pharmacology·D M BurnettA S Nies
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
May 1, 1989·Circulation·H K KroemerD M Roden
Nov 1, 1986·Journal of Pharmacological Methods·J Gal, T R Brown
Feb 1, 1986·British Journal of Clinical Pharmacology·A H ThomsonW S Hillis
Sep 23, 1988·Journal of Chromatography·M J WilsonT Walle
Apr 10, 1987·Journal of Chromatography·K M McErlaneC R Kerr
Jan 1, 1986·British Journal of Clinical Pharmacology·F FollathF Bühler
Feb 1, 1986·Journal of Medicinal Chemistry·E H BanittR A Newmark
Jan 11, 1985·Journal of Chromatography·O Grech-BélangerM Gilbert
Aug 1, 1985·Chest·M A Brodsky, B J Allen
Jul 1, 1984·Medicinal Research Reviews·M Simonyi
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
May 1, 1984·American Heart Journal·R L WoosleyD Roden
May 13, 1983·Journal of Chromatography·K M McErlane, G K Pillai
Jan 1, 1984·British Journal of Clinical Pharmacology·A J SedmanT P Moyer
Mar 9, 1984·Journal of Chromatography·A J Sedman, J Gal
Jun 8, 1984·Journal of Chromatography·A M AntonssonJ Vessman
Jul 1, 1984·European Journal of Drug Metabolism and Pharmacokinetics·K J HoffmannC Bäärnhielm
Mar 1, 1982·Circulation·L E Hinkle, H T Thaler
Jan 1, 1982·Biochemical Pharmacology·D E ClarkeB A Callingham
Citations
Jan 1, 1996·Chirality·I RondelliP Ventura
Jul 1, 1992·Biomedical Chromatography : BMC·N R Srinivas, L N Igwemezie
Jan 1, 1993·Biomedical Chromatography : BMC·H Y Aboul-Enein, S A Bakr
Nov 1, 1993·Journal of Pharmaceutical and Biomedical Analysis·C Boursier-NeyretC Sauveur
Sep 23, 1994·Journal of Chromatography. B, Biomedical Applications·S Görög, M Gazdag
Aug 7, 1992·Journal of Chromatography·D M Desai, J Gal
Aug 18, 1995·Journal of Chromatography. B, Biomedical Applications·E B ChristensenS N Rasmussen
Aug 31, 2011·Biomedical Chromatography : BMC·Ravi Bhushan, Rituraj Dubey
Apr 5, 2013·Biomedical Chromatography : BMC·Ravi Bhushan, Sonika Batra
Jul 2, 1993·Journal of Chromatography·D G FreitagF M Pasutto